Related Experiment Videos
The glycoprotein IIb/IIIa receptor inhibitor (abciximab) in ST-segment elevation myocardial infarction
A Mesquita1, J Baptista, J Palos
1Cardiology Division, Hospital de Santa Cruz, Av. Prof. Reynaldo dos Santos, 2795 Carnaxide, Portugal.
The Journal of Invasive Cardiology
|April 4, 2000
Abstract:
A successful therapy is presented using the antiplatelet agent abciximab, alone, in an ST-segment elevation acute myocardial infarction. The patient was treated in a center with permanent catheterization facilities. Clinical trials are necessary to validate the efficacy and the cost-effectiveness of this clinical decision and therapeutic option.